Duc Ha MD, MAS

Clinician Investigator

Duc HaDuc Ha MD, MAS, is an early-stage Clinician Investigator at the Kaiser Permanente Colorado Institute for Health Research. His research focuses on physical exercise across the lung cancer continuum. He is particularly interested in exploring the role of physical exercise to improve patient-reported and clinical outcomes in individuals eligible for lung cancer screening and lung cancer survivors eligible for long-term cure.

Dr. Ha received his medical training at the University of Colorado Denver School of Medicine, and completed a residency in Internal Medicine as well as fellowships in Pulmonary and Critical Care Medicine and Postdoctoral Research at the Cleveland Clinic. He completed a Master of Advanced Study (MAS) in clinical research at the University of California San Diego. His scholarly and research interests have taken him from the basic sciences starting with research in physical chemistry, biochemistry and molecular biology, to pre-clinical studies in pre-medical/medical training, with a transition to patient-oriented research in clinical case reports, retrospective analyses, and the recent completion of cross-sectional and prospective observational cohort studies. Currently, Dr. Ha is interested in interventional studies, including randomized clinical trials involving physical exercise to ultimately become an independent investigator focusing on improving lung cancer outcomes.

Dr. Ha is a long-standing member of the American Thoracic Society and more recently, the American Society of Clinical Oncology.


Selected Research

Current

  • The Lung PROSPR Research Center (Lung-PRC)
    Funder: National Cancer Institute
    Study End Date: 3/31/2023

  • Kaiser Permanente National Research Bank
    Funder: Kaiser Foundation Health Plan
    Study End Date: 12/31/2018

Complete

  • Assessment of Health in Lung Cancer Survivors
    The aims of this project are: (1) to assess patient-reported outcome measures in lung cancer survivors including for: generic and cancer-specific quality of life (QoL) and general cancer- and lung cancer-specific symptoms (e.g. fatigue, dyspnea, anxiety, depression, and sleep disturbances); (2) assess functional capacity in lung cancer survivors using the six-minute walk test; and (3) analyze the relationship between function capacity and QoL.
    Funder: National Cancer Institute
    Study End Date: 6/30/2018

  • Physiological and Patient-reported Outcome Assessments in Lung Cancer
    The aims of this project are: (1) in a cross-sectional study of lung cancer survivors eligible for long-term cure, assess and analyze the relationship between exercise physiological measures of health and patient-reported outcomes; and (2) in a prospective observational cohort study, quantify the health decrements associated with curative-intent lung cancer treatment using exercise physiological and patient-reported outcome measures.
    Funder: American Cancer Society
    Study End Date: 8/30/2018